Table 3.
Matrix effects of vitamin D3-free human serum on 25-OHD3-3-sulfate and 25-OHD3-3-glucuronide and their deuterated internal standards
25-OHD3-3-sulfate
|
25-OHD3-3-glucuronide
|
|||||||
---|---|---|---|---|---|---|---|---|
Analyte (10 nM) | IS | Analyte (180 nM) | IS | Analyte (1 nM) | IS | Analyte (18 nM) | IS | |
228 | 207 | 171 | 204 | 182 | 202 | 154 | 207 | |
Matrix effect (%)a | 217 | 218 | 176 | 148 | 196 | 165 | 158 | 124 |
223 | 189 | 178 | 164 | 194 | 210 | 164 | 140 | |
| ||||||||
N | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Average | 223 | 205 | 175 | 172 | 191 | 192 | 159 | 159 |
SD (%) | 5.1 | 14.6 | 4.0 | 28.8 | 7.6 | 24.1 | 5.0 | 5.0 |
The serum matrix effect (%) was calculated as the percentage of the peak area in the presence of matrix to the peak area in the absence of matrix.